Lifeboat Foundation

Seattle-based longevity biotech YouthBio Therapeutics has emerged from stealth mode, revealing it is working on the development of “gene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors.” The company boasts some top longevity science talent, with Dr João Pedro de Magalhães serving as its chief scientific officer and Dr Alejandro Ocampo as lead research collaborator.

Longevity. Technology: Cellular reprogramming is hot, hot hot! YouthBio joins a growing list of companies, including Altos Labs, Shift Bioscience and Turn Bio, among others, all aiming to change the course of human health through this exciting, yet early stage, science. Like everyone else, we’ll be watching all the players very closely – where will the first major breakthrough come from?

Cellular reprogramming is the process by which aged cells can be returned to a pluripotent (embryonic-like) state. This process, which can be achieved using Yamanaka factors, also improves the cells’ aging hallmarks. Partial reprogramming means that Yamanaka factors are induced only for short periods, which is not enough to fully change cells beyond a point of no return but is enough to induce rejuvenation.

A brighter future could be in store for people with a spinal cord injury if new animal research pans out in humans.

Mice that were paralyzed due to severe spinal cord damage regained the ability to walk within four weeks of receiving an experimental injectable therapy, say researchers led by Samuel Stupp of Northwestern University in Chicago.

The research team plans to seek U.S. Food and Drug Administration approval for the treatment to be used in people.

The condition stays with you for life once diagnosed, but treatments and specialists can help to manage the condition and its symptoms.

Experts are still unsure exactly what triggers the condition that affects more than 130,000 people in the UK.

According to the MS Society, people are most likely to find out they have MS in their thirties, forties and fifties in Britain, and the condition affects almost three times as many women as men.

California-based startup Bionaut Labs announces a unique robot. They are planning to send miniature robots deep inside into human skull to treat brain disorders. They will be using magnetic energy to propel the robots rather than optical or ultrasonic techniques.

#Miniaturerobot #Braindisorder #WION

Continue reading “Robots to cure Brain Disorder, startup sends miniature robot into Human Brain | WION” »

By isolating and reprogramming brain cells with dementia-causing genetic mutations, a team at JAX offers a powerful new research tool.

Understanding how we use our brain to make decisions is a daunting task, given our brain’s extensive webs of neural wiring and circuitry. Now, JAX researchers Erik Bloss and Kourtney Graham are using a surprising tool to investigate goal-directed behaviors: the rabies virus.

Neuroscientists from St. Petersburg University, led by Professor Allan V. Kalueff, in collaboration with an international team of IT specialists, have become the first in the world to apply the artificial intelligence (AI) algorithms to phenotype zebrafish psychoactive drug responses. They managed to train AI to determine—by fish response—which psychotropic agents were used in the experiment.

The research findings are published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The zebrafish (Danio rerio) is a freshwater bony fish that is presently the second-most (after mice) used model organism in biomedical research. The advantages for utilizing zebrafish as a model biological system are numerous, including low maintenance costs and high genetic and physiological similarity to humans. Zebrafish share 70% of genes with us. Furthermore, the simplicity of the zebrafish nervous system enables researchers to achieve more explicit and accurate results, as compared to studies with more complex organisms.

A new study, led by researchers from the University of California, Irvine, identifies a reason for why older adults are significantly more susceptible.

Small clinical trial suggests new, simple twist on cell therapies for cancer.

In a remarkable development, the National Aeronautics and Space Administration (NASA) ‘holoported’ the first human being into space late last year. Holoportation is the process through which a three dimensional holographic representation of an individual is created, in a combination of a ‘hologram’ and ‘teleportation’. NASA revealed the development late last week, as it announced that it had transported flight surgeon Dr. Josef Schmid, mixed and virtual reality firm AEXA Aerospance’s chief executive officer Dr. Fernando De La Pena Llaca and others to the International Space Station (ISS) during October 2021 while the ISS was orbiting the Earth at an altitude of 250 miles above the Earth’s surface.

NASA Uses Microsoft’s Hololens Konnect Camera To Create Live Hologram of Flight Surgeon In Space

The event place last year when NASA’s Crew 2 astronauts were present on the ISS. The astronauts took to the skies in April last year and returned in November, soon after Dr. Schmid and others were holoportated to the orbiting space laboratory.